Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys Inc.'s General Counsel and Corporate Secretary, Janet Lee, reported routine equity compensation activity involving restricted stock units. She exercised 699 restricted stock units into the same number of common shares, while 304 common shares were retained by the company to satisfy tax withholding obligations approved by the Compensation Committee. After these transactions, she holds 15,581 shares of common stock directly and 2,097 restricted stock units, which each convert into one share of Synopsys common stock as they continue to vest over time.
Cohn Jesse reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Jesse Cohn reported two stock awards of common stock as part of his board compensation. He received 372 shares and 710 shares at a stated price of $0.0000 per share, reflecting non-cash equity grants rather than open-market purchases.
After these awards, one line in the filing shows Cohn directly holding 1,082 shares of common stock, and another shows 710 shares held directly. Footnotes explain that 372 shares vest in three equal installments before each of the first three Annual Meetings following the grant date, while 710 shares vest before the first Annual Meeting following the grant date, in each case subject to continued Board service.
SYNOPSYS INC director Jesse Cohn filed an initial Form 3, which is the required statement of his beneficial ownership when becoming a director. The filing shows no reported transactions in Synopsys stock and no listed derivative positions, so it is an administrative disclosure rather than a trading event.
Synopsys reported a sharp revenue jump but much lower GAAP profit in its fiscal Q2 2026. Revenue rose to $2.28 billion, up 42% from a year earlier, helped by $652.4 million of contribution from the Ansys acquisition and strength across most of the business, partly offset by softness in Design IP.
Profitability dropped significantly under GAAP. Net income from continuing operations attributed to Synopsys fell to $17.1 million, with diluted EPS of $0.09 versus $2.24 a year earlier, as the company absorbed $403.6 million of amortization of acquired intangibles in the quarter, higher employee-related costs from added Ansys headcount, and $115.9 million of restructuring charges.
The balance sheet and cash flows show the impact of the Ansys deal and related financing. Six‑month operating cash flow surged to $1.49 billion, while total debt stood near $10.0 billion of Senior Notes after paying off prior term loans. Total assets were $46.9 billion, including $26.9 billion of goodwill and $11.9 billion of intangible assets, and backlog was about $11.0 billion. Synopsys also repurchased $262.5 million of stock, including a $250 million accelerated repurchase, and had $1.7 billion remaining under its authorization.
Synopsys reported a sharp revenue jump but much lower GAAP profit in its fiscal Q2 2026. Revenue rose to $2.28 billion, up 42% from a year earlier, helped by $652.4 million of contribution from the Ansys acquisition and strength across most of the business, partly offset by softness in Design IP.
Profitability dropped significantly under GAAP. Net income from continuing operations attributed to Synopsys fell to $17.1 million, with diluted EPS of $0.09 versus $2.24 a year earlier, as the company absorbed $403.6 million of amortization of acquired intangibles in the quarter, higher employee-related costs from added Ansys headcount, and $115.9 million of restructuring charges.
The balance sheet and cash flows show the impact of the Ansys deal and related financing. Six‑month operating cash flow surged to $1.49 billion, while total debt stood near $10.0 billion of Senior Notes after paying off prior term loans. Total assets were $46.9 billion, including $26.9 billion of goodwill and $11.9 billion of intangible assets, and backlog was about $11.0 billion. Synopsys also repurchased $262.5 million of stock, including a $250 million accelerated repurchase, and had $1.7 billion remaining under its authorization.
Synopsys, Inc. entered into a cooperation agreement with Elliott Investment Management and its affiliates, under which the Synopsys board will expand by one seat and appoint Jesse Cohn as an independent director effective June 1, 2026, with a term running through the 2027 annual meeting.
Under the agreement, Elliott accepts voting commitments, standstill and mutual non-disparagement provisions, including limits of up to 4.9% beneficial ownership and 7.5% aggregate economic exposure to Synopsys common stock during the cooperation period. Elliott must maintain at least a 1.5% net-long position to participate in selecting any replacement director. With Cohn’s appointment, the Synopsys board increases to 11 members and he will also serve on the Corporate Governance and Nominating Committee.
Synopsys, Inc. entered into a cooperation agreement with Elliott Investment Management and its affiliates, under which the Synopsys board will expand by one seat and appoint Jesse Cohn as an independent director effective June 1, 2026, with a term running through the 2027 annual meeting.
Under the agreement, Elliott accepts voting commitments, standstill and mutual non-disparagement provisions, including limits of up to 4.9% beneficial ownership and 7.5% aggregate economic exposure to Synopsys common stock during the cooperation period. Elliott must maintain at least a 1.5% net-long position to participate in selecting any replacement director. With Cohn’s appointment, the Synopsys board increases to 11 members and he will also serve on the Corporate Governance and Nominating Committee.
Synopsys reported strong top-line growth but sharply lower GAAP profit in its second quarter of fiscal 2026. Revenue reached $2.276 billion, up from $1.604 billion a year earlier, driven by gains in both time-based and upfront product revenue as well as maintenance and services.
GAAP net income from continuing operations fell to $17.1 million, or $0.09 per diluted share, compared with $349.2 million, or $2.24 per diluted share, reflecting large charges for amortization of acquired intangibles, stock-based compensation and restructuring.
On a non-GAAP basis, net income was $643.7 million, or $3.35 per diluted share, versus $572.7 million, or $3.67, showing higher profit dollars but slightly lower per-share earnings. The company raised its full-year 2026 targets, guiding revenue to $9.625–$9.705 billion and non-GAAP EPS to $14.72–$14.80, and now expects about $2.0 billion in free cash flow for the year.
Synopsys reported strong top-line growth but sharply lower GAAP profit in its second quarter of fiscal 2026. Revenue reached $2.276 billion, up from $1.604 billion a year earlier, driven by gains in both time-based and upfront product revenue as well as maintenance and services.
GAAP net income from continuing operations fell to $17.1 million, or $0.09 per diluted share, compared with $349.2 million, or $2.24 per diluted share, reflecting large charges for amortization of acquired intangibles, stock-based compensation and restructuring.
On a non-GAAP basis, net income was $643.7 million, or $3.35 per diluted share, versus $572.7 million, or $3.67, showing higher profit dollars but slightly lower per-share earnings. The company raised its full-year 2026 targets, guiding revenue to $9.625–$9.705 billion and non-GAAP EPS to $14.72–$14.80, and now expects about $2.0 billion in free cash flow for the year.
Synopsys executive Janet Lee reported routine equity compensation activity involving restricted stock units and related tax withholding. On 2026-05-16, 729 restricted stock units converted into the same number of shares of Synopsys common stock at a stated price of $0.0000 per share, reflecting a non-cash derivative exercise.
To cover tax obligations from this vesting, 318 shares of common stock were disposed of at $502.42 per share through share withholding approved by the Compensation Committee, as described in the footnotes. The filing also shows 5,103 restricted stock units remaining after these transactions.
Synopsys Inc ownership disclosure: Vanguard Capital Management reports 14,343,552 shares of Common Stock, representing 7.48% of the class as of 03/31/2026. The filing states Vanguard has sole voting power over 1,900,654 shares and sole dispositive power over 14,343,552 shares. The Schedule 13G is signed by Ashley Grim on 04/30/2026.
Synopsys, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on April 16, 2026. Stockholders approved an Amended and Restated Equity Incentive Plan that now allows non-employee directors, as well as executive officers, to receive equity awards.
They also re-elected ten directors, approved on an advisory basis the compensation of named executive officers, and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending October 31, 2026. A stockholder proposal to permit action by written consent did not receive sufficient support.
Vijayaraghavan Ravi K reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Vijayaraghavan Ravi K received an automatic stock award of 453 shares of common stock as a grant under the Amended and Restated Equity Incentive Plan. After this award, he directly holds 3,667 shares.
The shares subject to the award will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues serving on the Board through that date.